Mercedes Benz (China) Ltd will begin recalling 4,653 imported vehicles sold in China due to incorrect child-safety lock labels on June 19, according to the State Administration for Market Regulation.
The vehicles to be recalled are the G-class sedans manufactured between Feb 14, 2018, and Sept 24, 2019.
The embossed lock symbol on the rear doors of the said vehicles may indicate the incorrect child-safety lock staus, increasing the risk of injury in children if the door opens unexpectedly.
Mercedes Benz will install correct operating directions on the rear doors, free of charge.
In May, Mercedes-Benz sold over 70,000 passenger cars in China, achieving double-digit growth in China.
Britta Seeger, a board member of Daimler and Mercedes Benz, noted that their retail sales in China provided them with optimism.
China is Mercedes Benz's biggest market.


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Instagram Outage Disrupts Thousands of U.S. Users
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



